PLSE
Pulse Biosciences, Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Pulse Biosciences, Inc.
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last report0 of 8 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.
No other changes.
No other changes.
Largest filed tie
0
filed ties
No thesis.
Annual filing, covered
10-K parsed · Feb 19 '26
Supply-chain ties, covered
None disclosed
Fund holders, covered
N-PORT holdings
13F holdings, covered
13F quarter · Jun 30 '26
Management, not covered
Not covered · DEF 14A, 8-K 5.02
Company IR feed, not covered
News via newswires & EDGAR
Products, patents, hiring, not covered
Not covered
Annual filing, covered
10-K parsed · Feb 19 '26
Supply-chain ties, covered
None disclosed
Fund holders, covered
N-PORT holdings
13F holdings, covered
13F quarter · Jun 30 '26
Management, not covered
Not covered · DEF 14A, 8-K 5.02
Company IR feed, not covered
News via newswires & EDGAR
Products, patents, hiring, not covered
Not covered
+10.90%
vs ±11.7% implied · ×0.93
shaded = implied · ▲▼ = realized
Pulse Biosciences, Inc.
51.86
| Manager | Value | % base | |
|---|---|---|---|
| BlackRockindex-like | $40.7M | 13.60% | +9.47% |
| Bank of America | $40.1M | 13.41% | +67.03% |
| Vanguardindex-like | $21.9M | 7.31% | −3.34% |
| Portolan | $20.9M | 6.99% | +2.72% |
| T. Rowe Price | $20.8M | 6.94% | +4938.28% |
| Manager | Value | % base | |
|---|---|---|---|
| BlackRockindex-like | $40.7M | 13.60% | +9.47% |
| Bank of America | $40.1M | 13.41% | +67.03% |
| Vanguardindex-like | $21.9M | 7.31% | −3.34% |
| Portolan | $20.9M | 6.99% | +2.72% |
| T. Rowe Price | $20.8M | 6.94% | +4938.28% |
Same SIC code · 6
Same SEC industry code: Stryker Corp, 3M Co, Boston Scientific Corp and 3 more; of Pulse Biosciences, Inc.'s 6 closest co-movers, none share that code.
Same SIC code · 6
Same SEC industry code: Stryker Corp, 3M Co, Boston Scientific Corp and 3 more; of Pulse Biosciences, Inc.'s 6 closest co-movers, none share that code.
Bull2
Bear1
Expected move
No implied move.